AR013217A1 - COMPUESTOS DERIVADOS DE 24a, 24b-DIHOMO-9,10-SECOCOLESTANO POLINSATURADO, SU USO, PROCEDIMIENTO PARA PREPARARLOS, COMPUESTOS UTILES COMO INTERMEDIARIOS,Y UNA COMPOSICION FARMACEUTICA QUE COMPRENDE DICHO COMPUESTO DERIVADO - Google Patents
COMPUESTOS DERIVADOS DE 24a, 24b-DIHOMO-9,10-SECOCOLESTANO POLINSATURADO, SU USO, PROCEDIMIENTO PARA PREPARARLOS, COMPUESTOS UTILES COMO INTERMEDIARIOS,Y UNA COMPOSICION FARMACEUTICA QUE COMPRENDE DICHO COMPUESTO DERIVADOInfo
- Publication number
- AR013217A1 AR013217A1 ARP980103432A ARP980103432A AR013217A1 AR 013217 A1 AR013217 A1 AR 013217A1 AR P980103432 A ARP980103432 A AR P980103432A AR P980103432 A ARP980103432 A AR P980103432A AR 013217 A1 AR013217 A1 AR 013217A1
- Authority
- AR
- Argentina
- Prior art keywords
- compounds
- derivative
- dihomo
- prepare
- procedure
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 7
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 230000001419 dependent effect Effects 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000035475 disorder Diseases 0.000 abstract 2
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 abstract 1
- 208000032116 Autoimmune Experimental Encephalomyelitis Diseases 0.000 abstract 1
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 206010004146 Basal cell carcinoma Diseases 0.000 abstract 1
- 208000009329 Graft vs Host Disease Diseases 0.000 abstract 1
- 206010020649 Hyperkeratosis Diseases 0.000 abstract 1
- 201000002980 Hyperparathyroidism Diseases 0.000 abstract 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 abstract 1
- 208000001126 Keratosis Diseases 0.000 abstract 1
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 208000001647 Renal Insufficiency Diseases 0.000 abstract 1
- 206010040070 Septic Shock Diseases 0.000 abstract 1
- 206010052779 Transplant rejections Diseases 0.000 abstract 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 abstract 1
- 229930003316 Vitamin D Natural products 0.000 abstract 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 abstract 1
- 208000024908 graft versus host disease Diseases 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 230000003780 keratinization Effects 0.000 abstract 1
- 201000006370 kidney failure Diseases 0.000 abstract 1
- 208000032839 leukemia Diseases 0.000 abstract 1
- 201000006417 multiple sclerosis Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
- 230000036303 septic shock Effects 0.000 abstract 1
- 208000035408 type 1 diabetes mellitus 1 Diseases 0.000 abstract 1
- 235000019166 vitamin D Nutrition 0.000 abstract 1
- 239000011710 vitamin D Substances 0.000 abstract 1
- 150000003710 vitamin D derivatives Chemical class 0.000 abstract 1
- 229940046008 vitamin d Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Nutrition Science (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97112225 | 1997-07-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR013217A1 true AR013217A1 (es) | 2000-12-13 |
Family
ID=8227074
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980103432A AR013217A1 (es) | 1997-07-17 | 1998-07-15 | COMPUESTOS DERIVADOS DE 24a, 24b-DIHOMO-9,10-SECOCOLESTANO POLINSATURADO, SU USO, PROCEDIMIENTO PARA PREPARARLOS, COMPUESTOS UTILES COMO INTERMEDIARIOS,Y UNA COMPOSICION FARMACEUTICA QUE COMPRENDE DICHO COMPUESTO DERIVADO |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5994569A (enExample) |
| EP (1) | EP0998455B1 (enExample) |
| JP (1) | JP2001510183A (enExample) |
| AR (1) | AR013217A1 (enExample) |
| AU (1) | AU8860298A (enExample) |
| CA (1) | CA2296145A1 (enExample) |
| DE (1) | DE69818673T2 (enExample) |
| ES (1) | ES2206981T3 (enExample) |
| WO (1) | WO1999003828A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0957098A1 (en) * | 1998-05-14 | 1999-11-17 | F. Hoffmann-La Roche Ag | Intermediates for the synthesis of 3-epi vitamin D3 metabolites and analogs |
| ATE305506T1 (de) * | 1998-12-09 | 2005-10-15 | Protein Design Labs Inc | Verwendung von il-12 antikörpern zur behandlung von psoriasis |
| CA2390859A1 (en) * | 1999-12-02 | 2001-06-14 | The Penn State Research Foundation | Treatment of inflammatory bowel disease with vitamin d compounds |
| WO2008091686A2 (en) * | 2007-01-25 | 2008-07-31 | Bioxell S.P.A. | SYNTHESIS OF 1α-FLUORO-25-HYDROXY-16-23E-DIENE-26,27-BISHOMO-20-EPI-CHOLECALCIFEROL |
| CN114276284A (zh) * | 2021-12-30 | 2022-04-05 | 正大制药（青岛）有限公司 | 一种氟骨化醇的制备方法 |
| CN114957068A (zh) * | 2022-04-19 | 2022-08-30 | 正大制药（青岛）有限公司 | 一种氟骨化醇20s异构体的制备方法 |
| CN117018000B (zh) * | 2023-08-29 | 2025-01-28 | 东莞市东南部中心医院(东莞市东南部中医医疗服务中心) | 4-胆甾烯-3-酮在制备预防或治疗炎症性肠病药物中的应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8915770D0 (en) * | 1989-07-10 | 1989-08-31 | Leo Pharm Prod Ltd | Chemical compounds |
| US5532228A (en) * | 1990-02-06 | 1996-07-02 | Schering Aktiengesellschaft | Side-chain homologous vitamin D derivatives, process for their production, pharmaceutical preparations containing these derivatives and their use as pharmaceutical agents |
| EP0441467B1 (de) * | 1990-02-06 | 1994-06-01 | Schering Aktiengesellschaft | Seitenketten-homologe Vitamin-D-Derivate, Verfahren zu ihrer Herstellung, diese enthaltende pharmazeutische Präparate, sowie deren Verwendung als Arzneimittel |
| GB9017890D0 (en) * | 1990-08-15 | 1990-09-26 | Leo Pharm Prod Ltd | Chemical compounds i |
| GB9314400D0 (en) * | 1993-07-12 | 1993-08-25 | Leo Pharm Prod Ltd | Produktionsaktieselskab) chemical compounds |
| IL118156A (en) * | 1995-05-09 | 2001-08-26 | Duphar Int Res | Vitamin d compounds, their preparation and pharmaceutical compositions containing them |
| DE69606680T2 (de) * | 1995-10-30 | 2000-08-17 | F. Hoffmann-La Roche Ag, Basel | 1-Alpha, 26-dihydroxy-D-homo-vitamin D3 |
| WO1998018754A1 (en) * | 1996-10-28 | 1998-05-07 | Versicor, Inc. | Methods for solid-phase synthesis of hydroxylamine compounds and derivatives, and combinatorial libraries thereof |
| GB9622590D0 (en) * | 1996-10-30 | 1997-01-08 | Leo Pharm Prod Ltd | Chemical compounds |
-
1998
- 1998-07-10 WO PCT/EP1998/004293 patent/WO1999003828A1/en not_active Ceased
- 1998-07-10 EP EP98940201A patent/EP0998455B1/en not_active Expired - Lifetime
- 1998-07-10 DE DE69818673T patent/DE69818673T2/de not_active Expired - Fee Related
- 1998-07-10 CA CA002296145A patent/CA2296145A1/en not_active Abandoned
- 1998-07-10 AU AU88602/98A patent/AU8860298A/en not_active Abandoned
- 1998-07-10 JP JP2000503057A patent/JP2001510183A/ja active Pending
- 1998-07-10 ES ES98940201T patent/ES2206981T3/es not_active Expired - Lifetime
- 1998-07-14 US US09/115,188 patent/US5994569A/en not_active Expired - Fee Related
- 1998-07-15 AR ARP980103432A patent/AR013217A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999003828A1 (en) | 1999-01-28 |
| EP0998455A1 (en) | 2000-05-10 |
| ES2206981T3 (es) | 2004-05-16 |
| DE69818673T2 (de) | 2004-08-05 |
| AU8860298A (en) | 1999-02-10 |
| CA2296145A1 (en) | 1999-01-28 |
| DE69818673D1 (de) | 2003-11-06 |
| US5994569A (en) | 1999-11-30 |
| JP2001510183A (ja) | 2001-07-31 |
| EP0998455B1 (en) | 2003-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR014903A1 (es) | Compuestos del tipo 4-amino-fenilalanina inhibidores de la adhesion de leucocitos intermediada por vla-4, compuesto que son droga de dichos compuestos,composiciones farmaceuticas, metodo para adherir vla-4 en una muestra biologica, metodo para tratar una condicion inflamatoria | |
| DD202697A5 (de) | Verfahren zur herstellung von alkansaeuren und deren derivate | |
| AU7493698A (en) | Cyclic ether vitamin d3 compounds, 1alpha (oh) 3-epi-vitamin d3 compounds and uses thereof | |
| AR013217A1 (es) | COMPUESTOS DERIVADOS DE 24a, 24b-DIHOMO-9,10-SECOCOLESTANO POLINSATURADO, SU USO, PROCEDIMIENTO PARA PREPARARLOS, COMPUESTOS UTILES COMO INTERMEDIARIOS,Y UNA COMPOSICION FARMACEUTICA QUE COMPRENDE DICHO COMPUESTO DERIVADO | |
| EP0790824A1 (de) | 2,2-dichloralkancarbonsäuren, verfahren zu ihrer herstellung diese enthaltende arzneimittel, und ihre verwendung zur behandlung der insulinresistenz | |
| EP0353448A1 (de) | Sulfonamide, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel | |
| US20070032461A1 (en) | 1,3 Aclyated 24-keto-vitamin d3 compounds and methods of use thereof | |
| WO1998051664A1 (en) | 3-epi vitamin d2 compounds and uses thereof | |
| PE120899A1 (es) | Derivados de d-homo-9,10-seco-colesta-23-in-3,25-diol | |
| Beal III et al. | A total synthesis of a natural prostaglandin | |
| TW200702325A (en) | Synthesis of amino-alkoxy-heptanoic acid alkyl ester | |
| EP1622455A2 (en) | Gemini vitamin d3 compounds and methods of use thereof | |
| US20080280859A1 (en) | Gemini vitamin d3 compounds and methods of use thereof | |
| AR022235A1 (es) | Derivados de monosacaridos como inhibidores de la adhesion celular | |
| DK0500443T3 (da) | Phenylethanolamino- og phenylethanolaminomethyltetraliner, fremgangsmåde til deres fremstilling, mellemprodukter til denne fremgangsmåde og farmaceutiske præparater der indeholder dem | |
| AR012476A1 (es) | Derivados del 24-nor-secocola-5,7-dieno, su uso, procedimiento para prepararlos, composicion farmaceutica, y compuestos utiles como intermedios | |
| US20090099140A1 (en) | 20-Alkyl, Gemini Vitamin D3 Compounds and Methods of Use Thereof | |
| SU670198A3 (ru) | Инсектицидное средство | |
| FR2577928A1 (fr) | Analogues d'amino-prostaglandines a substituant thiabicycloheptane | |
| Honzawa et al. | Synthesis of a 1α-C-methyl analogue of 25-hydroxyvitamin D3: interaction with a mutant vitamin D receptor Arg274Leu | |
| WO2007038250A2 (en) | 1,25 - dihydroxy, 20-cyclopropyl, 26-27- deuteroalkyl vitamin d3 compounds and methods of use thereof | |
| CZ283306B6 (cs) | Asymetrická syntéza 3-substituovaných furanosidových sloučenin | |
| JP5989464B2 (ja) | 硫黄含有複環式化合物、及びその製造方法、並びに硫黄含有複環式化合物を含む組成物 | |
| KR20200089965A (ko) | 신규한 베타 셀레닐 케톤 유도체 및 이의 제조방법 | |
| ES8705359A1 (es) | Un procedimiento para la preparacion de un derivado de n-metil-1-alquiltio-2-nitroetonamina |